After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo

Research output: Contribution to journalComment/debate

Fingerprint Dive into the research topics of 'After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo'. Together they form a unique fingerprint.

Medicine & Life Sciences